X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (487) 487
Newsletter (38) 38
Newspaper Article (17) 17
Magazine Article (10) 10
Publication (10) 10
Book Review (6) 6
Trade Publication Article (5) 5
Transcript (4) 4
Book Chapter (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
mirabegron (539) 539
overactive bladder (265) 265
index medicus (204) 204
urinary incontinence (161) 161
urology & nephrology (151) 151
humans (148) 148
efficacy (147) 147
urinary bladder, overactive - drug therapy (113) 113
female (100) 100
beta-adrenoceptor agonist (95) 95
male (91) 91
safety (90) 90
acetanilides - therapeutic use (80) 80
double-blind (80) 80
thiazoles - therapeutic use (80) 80
aged (72) 72
care and treatment (72) 72
pharmacology & pharmacy (70) 70
middle aged (68) 68
bladder (60) 60
drug therapy (58) 58
solifenacin (57) 57
adrenergic beta-3 receptor agonists - therapeutic use (55) 55
tolerability (55) 55
treatment outcome (55) 55
acetanilides - adverse effects (53) 53
thiazoles - adverse effects (53) 53
research (50) 50
analysis (49) 49
urology (45) 45
quality-of-life (42) 42
adult (41) 41
antimuscarinics (41) 41
incontinence (39) 39
muscarinic antagonists - therapeutic use (39) 39
acetanilides - administration & dosage (38) 38
thiazoles - administration & dosage (38) 38
urinary-tract symptoms (38) 38
adrenergic beta-3 receptor agonists - adverse effects (37) 37
urinary bladder (37) 37
persistence (36) 36
urological agents - therapeutic use (36) 36
quality of life (35) 35
animals (34) 34
medicine & public health (33) 33
patients (33) 33
symptoms (33) 33
dosage and administration (31) 31
acetanilides - pharmacology (30) 30
thiazoles - pharmacology (30) 30
urinary-incontinence (30) 30
women (29) 29
therapy (28) 28
urinary bladder, overactive - physiopathology (28) 28
detrusor overactivity (27) 27
adrenergic beta-3 receptor agonists - pharmacology (26) 26
medical research (26) 26
urinary bladder - drug effects (26) 26
medicine, experimental (25) 25
selective beta-adrenoceptor agonist (25) 25
urological agents - adverse effects (25) 25
adherence (24) 24
aged, 80 and over (24) 24
beta-adrenoceptor (24) 24
reports (24) 24
dose-response relationship, drug (23) 23
management (23) 23
obstetrics & gynecology (23) 23
phase-3 (23) 23
tolterodine (23) 23
urodynamics (23) 23
adrenergic beta-3 receptor agonists - administration & dosage (22) 22
double-blind method (22) 22
health aspects (22) 22
prospective studies (22) 22
validation (22) 22
detrusor (21) 21
antimuscarinic (20) 20
pharmaceutical industry (20) 20
urological agents - administration & dosage (20) 20
diseases of the genitourinary system. urology (19) 19
rats (19) 19
urinary-bladder (19) 19
benign prostatic hyperplasia (18) 18
combination therapy (18) 18
pharmacokinetics (18) 18
pharmacology/toxicology (18) 18
usage (18) 18
acetanilides - pharmacokinetics (17) 17
adrenergic receptors (17) 17
beta-adrenoceptor agonist mirabegron (17) 17
clinical trials (17) 17
expression (17) 17
phase-iii (17) 17
review (17) 17
thiazoles - pharmacokinetics (17) 17
urinary bladder, overactive - diagnosis (17) 17
urination - drug effects (17) 17
adrenoceptor agonist (16) 16
drug therapy, combination (16) 16
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (525) 525
French (9) 9
Spanish (8) 8
German (7) 7
Czech (3) 3
Polish (2) 2
Russian (2) 2
Japanese (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Pharmacology, ISSN 0007-1188, 07/2019, Volume 176, Issue 14, p. 2525
Linked Articles 
Mirabegron
Journal Article
Der Urologe A, ISSN 0340-2592, 04/2019, Volume 58, Issue 4, p. 432
Journal Article
European Urology, ISSN 0302-2838, 2012, Volume 63, Issue 2, pp. 296 - 305
Abstract Background Despite several antimuscarinic treatment options for overactive bladder (OAB), there is still a need for distinct treatment approaches to... 
Urology | Tolterodine | Overactive bladder | Mirabegron
Journal Article
European Urology, ISSN 0302-2838, 2012, Volume 63, Issue 2, pp. 283 - 295
Abstract Background Mirabegron, a β3 -adrenoceptor agonist, has been developed for the treatment of overactive bladder (OAB). Objective To assess the efficacy... 
Urology | Mirabegron | β3-Adrenoceptor agonist | Overactive bladder (OAB) | Adrenoceptor agonist
Journal Article
CELL METABOLISM, ISSN 1550-4131, 01/2015, Volume 21, Issue 1, pp. 33 - 38
Increasing energy expenditure through activation of endogenous brown adipose tissue (BAT) is a potential approach to treat obesity and diabetes. The class of... 
SELECTIVE BETA-ADRENOCEPTOR AGONIST | THERMOGENESIS | ADRENOCEPTOR AGONIST | ENERGY-EXPENDITURE | COLD-EXPOSURE | METABOLISM | MIRABEGRON | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | FAT | ADULT HUMANS | CELL BIOLOGY
Journal Article
Progres en Urologie - FMC, ISSN 1761-676X, 09/2016, Volume 26, Issue 3, pp. F61 - F62
Overactive bladder (OAB) is defined by ICS (International Continence Society) as urgency, with or without urge incontinence, usually with frequency and... 
Anticholinergic | Overactive bladder | Mirabegron
Journal Article
Ceská gynekologie / Ceská lékarská spolecnost J. Ev. Purkyne, ISSN 1210-7832, 08/2015, Volume 80, Issue 4, pp. 244 - 248
Journal Article
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, ISSN 1931-857X, 10/2017, Volume 313, Issue 4, pp. F859 - F861
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 06/2018, Volume 829, pp. 79 - 84
Mirabegron is a β -adrenoceptor agonist and released on the marked for the treatment of overactive bladder. Because mirabegron is the only β -adrenoceptor... 
Cyclic AMP | Platelet aggregation | β3-adrenoceptor | Mirabegron
Journal Article
Journal Article
Journal of Urology, The, ISSN 0022-5347, 2017, Volume 197, Issue 4, pp. 1158 - 1163
Purpose Mirabegron (β3 adrenoreceptor agonist) is a new molecule with a mechanism of action distinct from antimuscarinics. Combination therapy with solifenacin... 
Urology | cholinergic antagonists | mirabegron | overactive | urinary bladder | BETA-ADRENOCEPTOR AGONIST MIRABEGRON | EFFICACY | SAFETY | DETRUSOR OVERACTIVITY | DOUBLE-BLIND | UROLOGY & NEPHROLOGY | SOLIFENACIN | Urinary incontinence | Care and treatment
Journal Article
Therapeutic Advances in Neurological Disorders, ISSN 1756-2864, 01/2019, Volume 12, p. 175628641984345
Background: We investigated the effectiveness and safety of mirabegron oral treatment in a group of patients with Parkinson’s disease (PD) and overactive... 
Journal Article
Neurourology and Urodynamics, ISSN 0733-2467, 08/2019, Volume 38, Issue 6, pp. 1792 - 1792
Journal Article
JOURNAL OF UROLOGY, ISSN 0022-5347, 10/2013, Volume 190, Issue 4, pp. 1320 - 1327
Purpose: Bladder outlet obstruction often presents as storage and voiding symptoms. We investigated urodynamic parameters in men with lower urinary tract... 
OVERACTIVE BLADDER | urinary bladder | TOLERABILITY | TOLTERODINE | MEN | UROLOGY & NEPHROLOGY | urinary bladder neck obstruction | urodynamics | mirabegron | lower urinary tract symptoms
Journal Article
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, ISSN 1756-2856, 05/2019, Volume 12, p. 1756286419843458
Background: We investigated the effectiveness and safety of mirabegron oral treatment in a group of patients with Parkinson's disease (PD) and overactive... 
Parkinson's disease | MANAGEMENT | EFFICACY | SAFETY | mirabegron | DYSFUNCTION | PREVALENCE | overactive bladder | CLINICAL NEUROLOGY | AGONIST
Journal Article
NATURE REVIEWS UROLOGY, ISSN 1759-4812, 06/2017, Volume 14, Issue 6, pp. 330 - 331
Data from an immunohistochemical study reveal abundant expression of beta(3)-adrenoceptors on cholinergic nerves of the human urinary bladder. This finding... 
URINARY-BLADDER | MIRABEGRON | UROLOGY & NEPHROLOGY | CONTRACTIONS
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 07/2015, Volume 758, pp. 115 - 122
Bladder overactivity (OAB) is a multifactorial bladder disorder that requires therapeutics superior to the current pharmacological treatment with muscarinic... 
β 3 -Adrenoreceptors | Pre-junctional receptors | Human detrusor | Overactive bladder | Acetylcholine release | Mirabegron
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.